Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Gains from Investment Securities (2023 - 2025)

SeaStar Medical Holding's Gains from Investment Securities history spans 3 years, with the latest figure at $1916.0 for Q3 2025.

  • For Q3 2025, Gains from Investment Securities rose 101.0% year-over-year to $1916.0; the TTM value through Dec 2025 reached -$284000.0, down 140.69%, while the annual FY2024 figure was $885.0, 90.97% down from the prior year.
  • Gains from Investment Securities reached $1916.0 in Q3 2025 per ICUCW's latest filing, up from -$16000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.8 million in Q1 2024 to a low of -$1.9 million in Q2 2024.
  • Average Gains from Investment Securities over 3 years is $13430.3, with a median of -$36000.0 recorded in 2023.
  • The largest YoY upside for Gains from Investment Securities was 8005.56% in 2024 against a maximum downside of 160.03% in 2024.
  • A 3-year view of Gains from Investment Securities shows it stood at $1.2 million in 2023, then crashed by 106.13% to -$76000.0 in 2024, then surged by 102.52% to $1916.0 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Gains from Investment Securities are $1916.0 (Q3 2025), -$16000.0 (Q2 2025), and $8817.0 (Q1 2025).